↓ Skip to main content

The Immunomodulatory Nutritional Intervention NR100157 Reduced CD4+ T-Cell Decline and Immune Activation: A 1-Year Multicenter Randomized Controlled Double-Blind Trial in HIV-Infected Persons Not…

Overview of attention for article published in Clinical Infectious Diseases, March 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
1 news outlet
twitter
2 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Immunomodulatory Nutritional Intervention NR100157 Reduced CD4+ T-Cell Decline and Immune Activation: A 1-Year Multicenter Randomized Controlled Double-Blind Trial in HIV-Infected Persons Not Receiving Antiretroviral Therapy (The BITE Study)
Published in
Clinical Infectious Diseases, March 2013
DOI 10.1093/cid/cit171
Pubmed ID
Authors

P. Cahn, K. Ruxrungtham, B. Gazzard, R.S. Diaz, A. Gori, D.P. Kotler, A. Vriesema, N. A. Georgiou, J. Garssen, M. Clerici, J. M. A. Lange

Abstract

The immunomodulatory nutritional product NR100157 was developed for human immunodeficiency virus (HIV)-infected individuals. We hypothesized that targeting the compromised gastrointestinal tract of HIV-infected individuals would result in systemic immunological benefits.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Argentina 1 4%
Unknown 26 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 26%
Student > Ph. D. Student 5 19%
Student > Master 5 19%
Student > Postgraduate 3 11%
Professor 3 11%
Other 4 15%
Readers by discipline Count As %
Medicine and Dentistry 10 37%
Agricultural and Biological Sciences 7 26%
Immunology and Microbiology 3 11%
Unspecified 2 7%
Biochemistry, Genetics and Molecular Biology 2 7%
Other 3 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 October 2013.
All research outputs
#922,960
of 12,023,873 outputs
Outputs from Clinical Infectious Diseases
#1,418
of 9,996 outputs
Outputs of similar age
#12,229
of 138,269 outputs
Outputs of similar age from Clinical Infectious Diseases
#24
of 196 outputs
Altmetric has tracked 12,023,873 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,996 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 138,269 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 196 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.